Researchers studying insulin resistance, glucose metabolism, and metabolic disease need blood from real diabetes patients. Type 1 and Type 2 both qualify.
Start Earning Now ›Lab-created samples can't replicate the complexity of a living patient's blood.
Diabetes research requires real-world biomarkers — HbA1c levels, insulin antibodies, C-peptide levels, and inflammatory markers that only come from actual patients managing the disease every day.
Your donation could contribute to next-generation insulin therapies, continuous glucose monitoring calibration, diabetic complication prevention, and metabolic disease drug trials.
Whether you're newly diagnosed or have been managing diabetes for decades, your blood carries biomarker data that researchers cannot synthesize in a lab. That's why diabetes donors consistently rank among the most in-demand profiles in the Helio network.
Pay depends on specimen type and study requirements.
Amounts are estimates. Final compensation is set by the study sponsor and confirmed before your appointment.
Three steps from sign-up to payment.
If you have diabetes, you almost certainly qualify.
Type 1 or Type 2 diagnosis — both qualify equally. Currently managing with insulin, metformin, sulfonylureas, GLP-1 agonists, or diet alone — all are welcome.
No minimum A1C required. Researchers need the full spectrum — well-controlled, moderately managed, and uncontrolled diabetes all serve different studies. Your current management approach is part of what makes your blood valuable.
Newly diagnosed patients welcome. Early-stage disease biomarkers are especially sought after for research into disease progression and early intervention.
Common questions from diabetes donors.
Create your profile in minutes. See which diabetes studies are recruiting now.
Get Matched Now ›